Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 145.80183.28-128.1825.75320.55

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 145.80 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024145.80
Mar2023183.28
Mar2022-128.18
Mar202125.75
Mar2020320.55

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2024 145.8
-20.45
Mar2023 183.28
Positive
Mar2022 -128.18
Negative
Mar2021 25.75
-91.97
Mar2020 320.55 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹124.6 Cr -3.4% -25.3% -50.5% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,550.5 Cr -7.8% -13.5% 91.7% Stock Analytics
KIRI INDUSTRIES ₹3,253.7 Cr -9.7% 0.7% 60.8% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,302.0 Cr -8.3% -2.9% 9.1% Stock Analytics
BODAL CHEMICALS ₹823.3 Cr 1.6% 1.4% -21.2% Stock Analytics
BHAGERIA INDUSTRIES ₹784.1 Cr -7.7% 2.6% 17.9% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.4%

-25.3%

-50.5%

SENSEX

-2.9%

-0.1%

6.8%


You may also like the below Video Courses